HealthQuill Drugs
artificial sweeteners are harmful to our health
Drugs Health

Artificial sweeteners spike insulin levels, increasing risk of heart diseases

HQ Team February 21, 2025: Artificial sweeteners, long used as low-calorie alternatives to sugar, are known to cause a number of health conditions,.

Read More
FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing the Anglo-Swedish firm to gain access to an anaemia drug in the world’s most populated nation.
Drugs Health Pharma

AstraZeneca Plc buys China unit of FibroGen Inc for $160 million

HQ Team February 21, 2025: FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing.

Read More
NCD cause of 81 percent deaths in under 70 says report
Drugs Health Research

28% of elderly Indians prescribed potentially harmful medications: Study

HQ Times February 19, 2025: A new study has revealed that 28 out of every 100 elderly individuals in India are being prescribed.

Read More
Merck & Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours, and who had prior treatment, has been “conditionally” approved by the European Commission, according to a company statement.
Drugs Health Medical

EC grants ‘conditional’ nod for Merck’s drug to treat VHL disease

HQ Team February 18, 2025: Merck and Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours and who had prior.

Read More
Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to the Massachusetts-based firm.
Drugs Health Medical

Bain Capital to buy Japan’s Mitsubishi Tanabe Pharma for $3.3 billion

Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to.

Read More
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs Pharma

AbbVie’s drug-resistant abdominal infection medicine gets US nod

HQ Team February 10, 2025: The U.S. Food and Drug Administration (FDA) has approved Emblaveo, a new antibiotic combination of aztreonam and avibactam,.

Read More
United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified pigs to treat kidney disease.
Drugs Health Medical

US regulator approves pig organ transplant trial to treat kidney disease 

United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified.

Read More
mrnA cancer vaccine
Drugs Medical

Tailored kidney cancer trial vaccine shows recurrence-free survival

HQ Team  February 6, 2025: A phase I clinical trial has shown that personalized cancer vaccines targeting driver mutations can lead to 100%.

Read More
Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.
Drugs Health Medical

Supernus’ injection to treat advanced Parkinson’s gets US regulator’s nod

Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.

Read More
All the US Agency for International Development (USAID) direct hire personnel have been placed on administrative leave globally.
Drugs Health Medical

Staff of USAID placed on leave, overseas missions may shut down

All the US Agency for International Development (USAID) direct hire personnel have been placed on administrative leave globally.

Read More